1
项与 Anti-CD22-CAR-transduced T cells(Affiliated Hospital to Academy of Military Medical Sciences) 相关的临床试验 / Unknown status临床1/2期IIT Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy Targeting CD22 in Treating Patients With B Cell Malignancies
The study will evaluate safety and efficacy of the CD22-targeted chimeric antigen receptor modified-T cell(CAR-T) cells in the treatment of B-cell Malignancies.
100 项与 Anti-CD22-CAR-transduced T cells(Affiliated Hospital to Academy of Military Medical Sciences) 相关的临床结果
100 项与 Anti-CD22-CAR-transduced T cells(Affiliated Hospital to Academy of Military Medical Sciences) 相关的转化医学
100 项与 Anti-CD22-CAR-transduced T cells(Affiliated Hospital to Academy of Military Medical Sciences) 相关的专利(医药)
100 项与 Anti-CD22-CAR-transduced T cells(Affiliated Hospital to Academy of Military Medical Sciences) 相关的药物交易